Intervest Bancshares (IBCA) 10.78 $IBCA 38.6% Return

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intervest Bancshares (IBCA) 10.78 $IBCA

38.6% Return Seen to Date on SmarTrend Intervest Bancshares Call (IBCA)
Comtex SmarTrend(R) - Mon Apr 13, 10:34AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 16 months, Intervest Bancshares has returned 38.65% as of today's recent price of $10.78.
IBCA: 10.78 (+0.21)

Intervest Bancshares Up 38.6% Since SmarTrend Uptrend Call (IBCA)
Comtex SmarTrend(R) - Thu Mar 26, 4:51PM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 15 months, Intervest Bancshares has returned 38.65% as of today's recent price of $10.78.
IBCA: 10.78 (+0.21)

Intervest Bancshares Has Returned 38.6% Since SmarTrend Recommendation (IBCA)
Comtex SmarTrend(R) - Wed Feb 18, 11:00AM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 14 months, Intervest Bancshares has returned 38.65% as of today's recent price of $10.78.
IBCA: 10.78 (+0.21)

Shares of IBCA Up 38.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 11, 9:36AM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 14 months, Intervest Bancshares has returned 38.65% as of today's recent price of $10.78.
IBCA: 10.78 (+0.21)

Bank of the Ozarks, Inc. Completes Acquisition of Intervest Bancshares Corporation
BusinessWire - Tue Feb 10, 4:00PM CST
Bank of the Ozarks, Inc. (NASDAQ: OZRK) announced today the completion of its acquisition of Intervest Bancshares Corporation ("Intervest" effective February 10, 2015 pursuant to a previously announced definitive agreement and plan of merger between Bank of the Ozarks, Inc. ("Company" and Intervest.
IBCA: 10.78 (+0.21), OZRK: 36.78 (+1.31)

Intervest Bancshares Shares Up 28.9% Since SmarTrend's Buy Recommendation (IBCA)
Comtex SmarTrend(R) - Tue Jan 27, 4:59PM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 13 months, Intervest Bancshares has returned 28.87% as of today's recent price of $10.02.
IBCA: 10.78 (+0.21)

Intervest Bancshares Corporation Reports 2014 Fourth Quarter Earnings of $3.9 Million or $0.18 per share and Full Year 2014 Earnings of $17.7 Million or $0.80 per share
BusinessWire - Tue Jan 20, 7:00AM CST
Intervest Bancshares Corporation (IBC) (NASDAQ-GS:IBCA), parent company of Intervest National Bank (INB), today announced that its net earnings available to common stockholders for the fourth quarter of 2014 (Q4-14) decreased slightly to $3.9 million, or $0.18 per share, from $4.2 million, or $0.19 per share, for the fourth quarter of 2013 (Q4-13). For the year 2014, net earnings available to common stockholders increased 32% to $17.7 million, or $0.80 per share, from $13.4 million, or $0.61 per share, for 2013.
IBCA: 10.78 (+0.21)

Shares of IBCA Up 29.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 13, 10:06AM CST
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 13 months, Intervest Bancshares has returned 29.90% as of today's recent price of $10.10.
IBCA: 10.78 (+0.21)

Intervest Bancshares declares dividend of USD0.05 per share for quarter
M2 - Wed Jan 07, 4:31AM CST
Intervest Bancshares Corporation (Nasdaq:IBCA), the holding company for Intervest National Bank, announced on Wednesday that it will pay a cash dividend of USD0.05 per share.
IBCA: 10.78 (+0.21)

Intervest Bancshares Corporation Announces Quarterly Dividend
BusinessWire - Tue Jan 06, 3:15PM CST
Intervest Bancshares Corporation (the "Company" (Nasdaq:IBCA), the holding company for Intervest National Bank, announced today the declaration of a cash dividend of $0.05 per share for holders of record as of January 16, 2015 and payable on January 26, 2015.
IBCA: 10.78 (+0.21)

Bank of the Ozarks announces closure of merger with Intervest Bancshares in February
M2 - Fri Jan 02, 4:35AM CST
Bank of the Ozarks Inc (NASDAQ:OZRK), a bank holding company, on Thursday jointly reported with Intervest Bancshares Corporation (NASDAQ:IBCA) that the earlier declared merger transaction will close on or about 10 February 2015.
IBCA: 10.78 (+0.21), OZRK: 36.78 (+1.31)

Bank of the Ozarks, Inc. and Intervest Bancshares Corporation Announce Expected Closing Date for Pending Merger
BusinessWire - Wed Dec 31, 3:05PM CST
Bank of the Ozarks, Inc. ("Ozarks" (NASDAQ: OZRK) and Intervest Bancshares Corporation ("Intervest" (NASDAQ: IBCA) today jointly announced that the companies expect the previously announced merger transaction will close on or about February 10, 2015, subject to satisfaction of the remaining closing conditions set forth in the merger agreement, including the approval and adoption of the merger agreement by Intervest's stockholders at the special meeting of stockholders scheduled for January 27, 2015. All required regulatory approvals for the merger of Intervest with and into Ozarks have been received.
IBCA: 10.78 (+0.21), OZRK: 36.78 (+1.31)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 158

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Zadarma Unveils Innovative Multilingual AI Voice Assistant

Updated Category News Views 106

Introducing the Zadarma AI Voice Agent Zadarma, recognized for its exceptional VoIP services, has introduced an innovative virtual assistant - the Zadarma AI Voice Agent. This cutting-edge tool is designed to revolutionize customer interactions by providing seamless call handling, whether during traditional business hours or after hours. 24/7 Customer Support The Zadarma...

Continue Reading
Exploring Shift4 Payments Inc.'s P/E Ratio Trends and Insights

Updated Category News Views 199

Analyzing Shift4 Payments Inc. Stock Performance Shift4 Payments Inc. (NYSE: FOUR) is currently valued at $93.44, reflecting a decrease of 1.22% in today’s trading session. Despite this minor drop, there is good news: over the last month, the stock has climbed by 7.41%, and impressively, it has surged by 102.95% within the past year. This rapid appreciation has led many...

Continue Reading
SkyWest Insider Sells $2.01 Million Worth of Shares

Updated Category News Views 97

Wade J Steel Executes Major Sell Order of SkyWest Stock A significant insider transaction has come to light with Wade J Steel, Chief Commercial Officer at SkyWest (NASDAQ: SKYW), recently selling shares of the company worth $2.01 million. This transaction was documented through the latest SEC filing. Understanding the Sale The SEC filing revealed that Steel sold a total...

Continue Reading
Marpai Inc. to Discuss 2024 Financial Results in Upcoming Webcast

Updated Category News Views 140

Marpai Inc. Announces Webcast for Financial Results Marpai, Inc. is set to hold a conference call and webcast aimed at presenting vital operational and financial details surrounding its results for 2024. They are a leading technology platform company, operating as a respected Third-Party Administrator (TPA) within the health insurance sector. Marpai actively works to...

Continue Reading
Marex Group Investors Urged to Act Ahead of Critical Deadline

Updated Category News Views 160

Understanding the Legal Landscape for Marex Group Investors As an investor in Marex Group plc (NASDAQ: MRX), it's essential to stay informed and proactive regarding upcoming legal proceedings that may affect your investments. The Rosen Law Firm, a global leader in investor rights, has announced an important deadline for shareholders who purchased securities during a...

Continue Reading